FDA panel unanimously backs Celltrion's Rituxan biosimilar
admin 10th October 2018 Uncategorised 0An independent panel of FDA advisors endorsed Celltrion’s Rituxan biosimilar, sending the program to the FDA for a final say.
More: FDA panel unanimously backs Celltrion's Rituxan biosimilar
Source: fierce